Most importantly, the bill extends the FDA's budget for reviewing new drugs and medical implants, but lawmakers have added dozens more provisions.
The Basel, Switzerland-based company says its closure of the site in Nutley, N.J., will consolidate R&D with operations in Switzerland and Germany.
Teva had accused rival companies of infringing on patents covering the drug's chemical composition, and will now be free from generic competition until 2014.
Implants made with metal stems and sockets have been recently favored over ceramic versions, but U.K. surgeons say they're falling faster than expected.
Roche Diagnostics Corp. says it plans to spend $300 million over the next decade on projects at its North American headquarters in Indianapolis.
The biopharmaceutical firm says it will establish its global headquarters in New Haven with $20 million in loan forgiveness based on successful job creation.
Medical device maker Hologic came a step closer to completing its $3.76 billion acquisition of diagnostic test maker Gen-Probe after it passed a regulatory bar.
A top British medical expert says faulty French-made breast implants do not pose any long-term health problems to women.
Medical device maker CryoLife Inc. said Thursday it agreed to settle lawsuits with Medafor Inc. and CardioFocus Inc.
Johnson & Johnson will have to sell its system for surgically treating serious wrist fractures to win clearance of its $21.3 billion acquisition of Synthes.
Saint-Gobain Performance Plastics (SGPPL) HealthCare Markets, a leading supplier of high-performance medical device components, introduces Compass Technology, a new co-development for silicone extrusion.
While J&J insists its products are safe and that it is not recalling them, the FDA argues the company's methods are less effective than traditional procedures.
Rep. Erik Paulsen, R-Minn. said the 2.3 percent tax would eat up dollars that otherwise might go toward research and development — and jobs.
A man's widow and daughter sued Philip Morris, R.J. Reynolds, Lorillard and Liggett, blaming his death on an unbreakable cigarette habit.
The FDA says a J&J unit received 227 complaints about various products and most often closed them without a thorough investigation.
U.S. regulators would inspect more drug manufacturing facilities in China, India and other foreign countries in order to ensure quality.
Medical device maker Boston Scientific Corp. said it received U.S. approval for a new type of stent to treat blocked arteries in the legs.
Agilent Technologies Inc. said it is buying the cancer diagnostic company to help it develop a wider range of cancer-fighting products.
Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft.
Medical device maker has agreed to buy Hemosphere Inc., which makes a vascular graft that is used in kidney dialysis patients, for $17 million in cash.
Shares of the medical diagnostics company slipped after it announced that the government was concerned over its marketing and quality-control testing.
There is nothing worse than throwing a bunch of consultants at a problem without knowing the boundaries of the project or defining the expected results. Unfortunately, it happens all the time. It ends in frustration for all parties involved. A formal scope of work (SOW) helps both the client and the consultant to set expectations of each other, and agree on basic assumptions that are critical to success.
The company said there were no allegations that drugs were illegally diverted to someone without prescriptions and no patients were harmed.
The two men performed pioneering research on how cells express their genetic information at The Rockefeller University in New York City.